May 7-11, 2024

27th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer  presented “Balancing careers in Academia and Industry to Accelerate the Development of in vivo targeting genetic medicines” and Karina Krotova, Ph.D., Principal Scientist, Imanis Life Sciences presented “In Vivo Generation of αCD19-CAR T Cells Using a Novel LV-based Platform Successfully Clears Advanced NALM-6 Tumor without Noticeable Toxicity”. Kah-Whye Peng, Ph.D., Vyriad Chief Technical Officer and Luke Russell, Ph.D., Vyriad Director for Business Development & Strategic Alliances attended the ASGCT Annual Meeting in Baltimore, MD.